SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lehto J)
 

Sökning: WFRF:(Lehto J) > PFKFB3 Inhibition S...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002810naa a2200397 4500
001oai:prod.swepub.kib.ki.se:147131054
003SwePub
008240701s2021 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1471310542 URI
024a https://doi.org/10.3390/cancers131436042 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Ninou, AH4 aut
2451 0a PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
264 c 2021-07-18
264 1b MDPI AG,c 2021
520 a Replicative repair of interstrand crosslinks (ICL) generated by platinum chemotherapeutics is orchestrated by the Fanconi anemia (FA) repair pathway to ensure resolution of stalled replication forks and the maintenance of genomic integrity. Here, we identify novel regulation of FA repair by the cancer-associated glycolytic enzyme PFKFB3 that has functional consequences for replication-associated ICL repair and cancer cell survival. Inhibition of PFKFB3 displays a cancer-specific synergy with platinum compounds in blocking cell viability and restores sensitivity in treatment-resistant models. Notably, the synergies are associated with DNA-damage-induced chromatin association of PFKFB3 upon cancer transformation, which further increases upon platinum resistance. FA pathway activation triggers the PFKFB3 assembly into nuclear foci in an ATR- and FANCM-dependent manner. Blocking PFKFB3 activity disrupts the assembly of key FA repair factors and consequently prevents fork restart. This results in an incapacity to replicate cells to progress through S-phase, an accumulation of DNA damage in replicating cells, and fork collapse. We further validate PFKFB3-dependent regulation of FA repair in ex vivo cultures from cancer patients. Collectively, targeting PFKFB3 opens up therapeutic possibilities to improve the efficacy of ICL-inducing cancer treatments.
700a Lehto, J4 aut
700a Chioureas, D4 aut
700a Stigsdotter, Hu Karolinska Institutet4 aut
700a Schelzig, K4 aut
700a Akerlund, E4 aut
700a Gudoityte, Gu Karolinska Institutet4 aut
700a Joneborg, Uu Karolinska Institutet4 aut
700a Carlson, J4 aut
700a Jonkers, J4 aut
700a Seashore-Ludlow, Bu Karolinska Institutet4 aut
700a Gustafsson, NMS4 aut
710a Karolinska Institutet4 org
773t Cancersd : MDPI AGg 13:14q 13:14x 2072-6694
856u https://www.mdpi.com/2072-6694/13/14/3604/pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:147131054
8564 8u https://doi.org/10.3390/cancers13143604

Hitta via bibliotek

  • Cancers (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy